Cargando…

Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl

BACKGROUND: The purpose of the present work is to mask the intensely bitter taste of Itopride HCl and to formulate an Oro dispersible tablet (ODT) of the taste-masked drug by incorporation of microspheres in the tablets for use in specific populations viz. pediatrics, geriatrics and patients experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sanjay, Madan, Sarika, Agrawal, SS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555840/
https://www.ncbi.nlm.nih.gov/pubmed/23351176
http://dx.doi.org/10.1186/2008-2231-20-24
_version_ 1782257089620475904
author Shah, Sanjay
Madan, Sarika
Agrawal, SS
author_facet Shah, Sanjay
Madan, Sarika
Agrawal, SS
author_sort Shah, Sanjay
collection PubMed
description BACKGROUND: The purpose of the present work is to mask the intensely bitter taste of Itopride HCl and to formulate an Oro dispersible tablet (ODT) of the taste-masked drug by incorporation of microspheres in the tablets for use in specific populations viz. pediatrics, geriatrics and patients experiencing difficulty in swallowing. METHODS: With this objective in mind, microspheres loaded with Itopride HCl were prepared by solvent evaporation method using acetone as solvent for pH-sensitive polymer, Eudragit EPO and light liquid paraffin as the encapsulating medium. The prepared microspheres were characterized with regard to yield, drug content, flow properties, particle size and size distribution, surface features, in vitro drug release and taste. The ODTs so prepared from these microspheres were evaluated for hardness, thickness, weight variation, friability, disintegration time, drug content, wetting time, water absorption ratio, moisture uptake, in vitro dispersion, in vitro disintegration, in vitro drug release and stability. RESULTS: The average size of microspheres was found to be satisfactory in terms of the size and size distribution. Microspheres prepared were of a regular spherical shape. Comparison of the dissolution profiles of microspheres in different pH media showed that microspheres having drug: polymer ratio of 1:2 produced a retarding effect in simulated salivary fluid (pH 6.8) and were further used for formulation into ODTs after addition of suitable amounts of excipients such as superdisintegrant, diluent, sweetener and flavor of directly compressible grade. CONCLUSIONS: Effective taste-masking was achieved for Itopride HCl by way of preparation of microspheres and ODTs of acceptable characteristics.
format Online
Article
Text
id pubmed-3555840
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35558402013-01-31 Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl Shah, Sanjay Madan, Sarika Agrawal, SS Daru Research Article BACKGROUND: The purpose of the present work is to mask the intensely bitter taste of Itopride HCl and to formulate an Oro dispersible tablet (ODT) of the taste-masked drug by incorporation of microspheres in the tablets for use in specific populations viz. pediatrics, geriatrics and patients experiencing difficulty in swallowing. METHODS: With this objective in mind, microspheres loaded with Itopride HCl were prepared by solvent evaporation method using acetone as solvent for pH-sensitive polymer, Eudragit EPO and light liquid paraffin as the encapsulating medium. The prepared microspheres were characterized with regard to yield, drug content, flow properties, particle size and size distribution, surface features, in vitro drug release and taste. The ODTs so prepared from these microspheres were evaluated for hardness, thickness, weight variation, friability, disintegration time, drug content, wetting time, water absorption ratio, moisture uptake, in vitro dispersion, in vitro disintegration, in vitro drug release and stability. RESULTS: The average size of microspheres was found to be satisfactory in terms of the size and size distribution. Microspheres prepared were of a regular spherical shape. Comparison of the dissolution profiles of microspheres in different pH media showed that microspheres having drug: polymer ratio of 1:2 produced a retarding effect in simulated salivary fluid (pH 6.8) and were further used for formulation into ODTs after addition of suitable amounts of excipients such as superdisintegrant, diluent, sweetener and flavor of directly compressible grade. CONCLUSIONS: Effective taste-masking was achieved for Itopride HCl by way of preparation of microspheres and ODTs of acceptable characteristics. BioMed Central 2012-09-03 /pmc/articles/PMC3555840/ /pubmed/23351176 http://dx.doi.org/10.1186/2008-2231-20-24 Text en Copyright ©2012 Shah et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shah, Sanjay
Madan, Sarika
Agrawal, SS
Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
title Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
title_full Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
title_fullStr Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
title_full_unstemmed Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
title_short Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
title_sort formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555840/
https://www.ncbi.nlm.nih.gov/pubmed/23351176
http://dx.doi.org/10.1186/2008-2231-20-24
work_keys_str_mv AT shahsanjay formulationandevaluationofmicrospherebasedorodispersibletabletsofitopridehcl
AT madansarika formulationandevaluationofmicrospherebasedorodispersibletabletsofitopridehcl
AT agrawalss formulationandevaluationofmicrospherebasedorodispersibletabletsofitopridehcl